Circumvent
Utilizing monogenic disorders to inform and solve highly complex…
- Employees
- 1–10
- Total Funding
- $495K
- Last Round
- $495K SeedOct 2021
- Rounds
- 2
About
Utilizing monogenic disorders to inform and solve highly complex…
Summary
Circumvent is a Biotech company. It has raised $495K in total across 2 rounds, most recently a $495K Seed round in Oct 2021. Investors include HHS NIH SBIR Phase II, Y Combinator Continuity Fund and Heritage Provider Network.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2021
Sign up to see all 2 rounds
Grant through Seed — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Neuralink is building a brain-computer interface for medical needs and greater human potential.
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Genomics and data analytics company providing drug discovery and development services to global b...
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/circumvent-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/circumvent-pharmaceuticals" alt="Circumvent on Indexed.vc" width="260" height="76" /></a>